期刊文献+

Treatment Effects of Integrated TCM and Western Medicine Treatment Scheme on COVID-19: A Single-armed Clinical Trial

原文传递
导出
摘要 Backgroud:The outbreak of COVID-19 has brought unprecedented perils to human health and raised public health concerns in more than two hundred countries.Safe and effective treatment scheme is needed urgently.Objective:To evaluate the effects of integratedTCM and western medicine treatment scheme on COVID-19.Methods:A single-armed clinical trial was carried out in Hangzhou Xixi Hospital,an affiliated hospital with Zhejiang Chinese Medical University.102 confirmed cases were screened out from 725 suspected cases and 93 of them were treated with integrated TCM and western medicine treatment scheme.Results:83 cases were cured,5 cases deteriorated,and 5 cases withdrew from the study.No deaths were reported.The mean relief time of fever,cough,diarrhea,and fatigue were(4.78±4.61)days,(7.22±4.99)days,(5.28±3.39)days,and(5.28±3.39)days,respectively.It took(14.84±5.50)days for SARS-CoV-2 by nucleic acid amplification-based testing to turn negative.Multivariable cox regression analysis revealed that age,BMI,PISCT,BPC,AST,CK,BS,and UPRO were independent risk factors for COVID-19 treatment.Conclusion:Our study suggested that integrated TCM and western medicine treatment scheme was effective for COVID-19.
出处 《Clinical Complementary Medicine and Pharmacology》 2021年第1期77-83,共7页 临床补充医学和药理学(英文)
基金 This Research was Supported by Zhejiang Provincial Natural Science Foundation of China‘Emergency Prevention and Treatment of COVID-19′,Under Grated NO.LEZ20H190001 and COVID-19 prevention and control special scientific research project of Hangzhou Science and Tech-nology Bureau,China.
  • 相关文献

参考文献4

二级参考文献42

  • 1陈曦,李凡.Glucosamine Chondroitin与黄芩联合对佐剂性关节炎大鼠血清PGE2影响的实验研究[J].中国实验诊断学,2005,9(1):15-17. 被引量:17
  • 2杨巧芳,孟庆刚,洪志强,李瑞.黄芩泻火解毒功效评述[J].中华中医药学刊,2007,25(8):1597-1598. 被引量:15
  • 3[2]中国疾病预防与控制中心:SARS的治疗指引http://www.satcm. gov. cn/lanmu/feidian/tcm030606jieshao. htm (2003 年7月 29 日).China Center for Disease Control and Prevention: Treatment Guidance for SARS. http://www. satcm. gov. cn/lanmu/feidian/tcm030606jieshao. htm(July 29, 2003).
  • 4[3]WHO: Cumulative Number of Reported Probable Cases of SARS. Geneva: World Health Organization, June 4, 2003.http://www. who. int/csr/sars/country/2003 06 - 03/en/(accessed on July 29,2003).
  • 5[5]General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. World Health Organization,Geneva 2000.
  • 6[6]Lam CLK, Gondek B, Ren XS. Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36Healthy Survey. J Clin Epidemiol 1998; 51 ( 11 ): 1139.
  • 7[7]Poon PMK, Wong CK, Fong CYS, et al. Immunomodulatory effects of an anti-viral traditional Chinese medicine. The 33rd Annual Meeting of the Japanese Society for Immunology, 2003December 8 - 9; Fukuoka, Japan.
  • 8[8]Yamada H, Nagai T. In vivo antiinfluenza virus activity of Kampo medicine Sho-seiryu-to through mucosal immune system. Exp Clin Pharmacol 1998;20: 185-192.
  • 9崔晓燕,王素霞,候永利.金银花提取物的抗炎机制研究[J].中国药房,2007,18(24):1861-1863. 被引量:57
  • 10张望望,张文书.穿心莲抗炎作用机制研究[J].医学综述,2008,14(6):938-939. 被引量:5

共引文献134

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部